Use of in vitro-in vivo correlation to predict the pharmacokinetics of several products containing a BCS class 1 drug in extended release matrices.

Autor: Mirza T; Food and Drug Administration Division of Product Quality Research, CDER/OPS/OTR/DPQR, White Oak, LS Building 64 10903 New Hampshire Ave, Silver Spring, Maryland 20993, USA. Tahseen.mirza@fda.hhs.gov, Bykadi SA, Ellison CD, Yang Y, Davit BM, Khan MA

Publikováno v: Pharmaceutical research [Pharm Res] 2013 Jan; Vol. 30 (1), pp. 179-90. Date of Electronic Publication: 2012 Aug 22.